SCN10A and cancer: Recently, Qiu and colleagues [10] have observed an increased expression of Nav1.8 within DRG in a rat model of Walker 256 tumor cell-induced bone cancer pain, suggesting the potential involvement of Nav1.8 in the development of cancer-induced bone pain.